Industry News

Sep 25, 2026

Physics-grounded AI is getting Galux hits on the hardest antibody targets

The Seoul based company has built a physics-grounded design platform, validated it by cryo-EM, and pointed it at the targets antibody discovery has always struggled with.

Bio Design

Biomanufacturing Scale Up

Chemicals Materials

Food Agriculture

Aaron Blotnick

Sep 23, 2026

Saku Biosciences and Sable Fermentation Offer US Customers One Agreement From Strain Engineering Through Scale Up

Bio Design

Biomanufacturing Scale Up

Chemicals Materials

Food Agriculture

Aaron Blotnick

Sep 23, 2026

Saku Biosciences and Sable Fermentation Offer US Customers One Agreement From Strain Engineering Through Scale Up

Food Agriculture

Mohamed Soufi

Sep 17, 2026

Leaps by Bayer Leads Series A in Robigo, Betting on Engineered Microbes for Crop Protection

Food Agriculture

Mohamed Soufi

Sep 17, 2026

Leaps by Bayer Leads Series A in Robigo, Betting on Engineered Microbes for Crop Protection

Capital Markets

Biopharma Solutions Tools Tech

Sep 15, 2026

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Capital Markets

Biopharma Solutions Tools Tech

Sep 15, 2026

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Biopharma Solutions Tools Tech

Sep 15, 2026

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Biopharma Solutions Tools Tech

Sep 15, 2026

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

SynBioBeta

2027

May 3-6,

2027

San Jose Convention Center ·

CA, USA

Event Details

Join List

More Industry News

Capital Markets

Engineered Human Therapies

Sep 15, 2026

Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines

Capital Markets

Engineered Human Therapies

Sep 15, 2026

Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines

Biomanufacturing Scale Up

Engineered Human Therapies

Biopharma Solutions Tools Tech

Sep 15, 2026

Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing

Biomanufacturing Scale Up

Engineered Human Therapies

Biopharma Solutions Tools Tech

Sep 15, 2026

Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing

Engineered Human Therapies

Biopharma Solutions Tools Tech

Sep 15, 2026

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

Engineered Human Therapies

Biopharma Solutions Tools Tech

Sep 15, 2026

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

Engineered Human Therapies

Biopharma Solutions Tools Tech

Longevity

Sep 15, 2026

Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic Diseases

Engineered Human Therapies

Biopharma Solutions Tools Tech

Longevity

Sep 15, 2026

Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic Diseases

Ai Digital Biology

Biomanufacturing Scale Up

Biopharma Solutions Tools Tech

Sep 15, 2026

Ridge Biotechnologies Expands Investor Base as Demand Accelerates for AI-Designed Bioconjugate Therapeutics

Ai Digital Biology

Biomanufacturing Scale Up

Biopharma Solutions Tools Tech

Sep 15, 2026

Ridge Biotechnologies Expands Investor Base as Demand Accelerates for AI-Designed Bioconjugate Therapeutics

Capital Markets

Sep 15, 2026

Luma Group Successfully Closes LumaBio Fund I at $410 Million

Capital Markets

Sep 15, 2026

Industry News

Physics-grounded AI is getting Galux hits on the hardest antibody targets

Saku Biosciences and Sable Fermentation Offer US Customers One Agreement From Strain Engineering Through Scale Up

Saku Biosciences and Sable Fermentation Offer US Customers One Agreement From Strain Engineering Through Scale Up

Leaps by Bayer Leads Series A in Robigo, Betting on Engineered Microbes for Crop Protection

Leaps by Bayer Leads Series A in Robigo, Betting on Engineered Microbes for Crop Protection

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Newsletter

More Industry News

More Industry News

More Industry News

Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines

Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines

Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing

Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic Diseases

Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic Diseases

Ridge Biotechnologies Expands Investor Base as Demand Accelerates for AI-Designed Bioconjugate Therapeutics

Ridge Biotechnologies Expands Investor Base as Demand Accelerates for AI-Designed Bioconjugate Therapeutics

Luma Group Successfully Closes LumaBio Fund I at $410 Million

Luma Group Successfully Closes LumaBio Fund I at $410 Million

Newsletter

Newsletter

SynBioBeta 2027

Categories

Company

Newsletter

SynBioBeta 2027

Categories

Company

Newsletter

SynBioBeta 2027

Categories

Company